Dr. Kennedy answers the question: 'Carbamazepine For Bipolar Disorder?' — -- Question: How is carbamazepine (Tegretol) used in the treatment of bipolar disorder? What are the side effects and ...

Health Canada has issued an advisory concerning carbamazepine, a drug commonly used to treat epilepsy, mania, bipolar disorder and trigeminal neuralgia, a facial condition. Carbamazepine is sold in ...

Tegretol Dosage. Therapy should be prescribed only tegretol carbamazepine 200mg critical benefit-to-risk appraisal in patients with a history of cardiac conduction disturbance, more care for these ...

HAWTHORNE, N.Y.--(BUSINESS WIRE)--Taro Pharmaceutical Industries Ltd. (“Taro” or the “Company,” Pink Sheets: TAROF) today reported that it received final approval from the U.S. Food and Drug ...

WASHINGTON The Food and Drug Administration has announced that manufacturers of drugs containing the active ingredient carbamazepine have agreed to add the recommendation that before starting therapy ...

A new generic product is making its debut from Upsher-Smith. The company is launching carbamazepine extended-release tablets, which are available in three dosage strengths — 100 mg, 200 mg and 400 mg.

BOSTON (MarketWatch) -- The Food and Drug Administration is advising healthcare professionals to screen Asian patients for a certain genetic trait before prescribing the anticonvulsant drug ...

Violet See, PharmD St. 800 mg tegretol conchas of carbamazepine 800 mg tegretol on stopping versus classical previous alcohol professionals in an outpatient randomized trial. J Gen Vial Med ; — ...

Alembic Pharmaceuticals on Monday said it has received final approval from the US health regulator for its generic version of Carbamazepine extended-release tablets indicated for treatment of seizures ...

Question: I have tic douloureux and would like the latest information you have on it. Is it possible to have it on both sides of the face? I feel twinges on the other side once in a while, but I think ...

Sept. 27, 2005 — The U.S. Food and Drug Administration (FDA) and AstraZeneca have notified healthcare professionals via letter regarding medication error reports ...